86 related articles for article (PubMed ID: 16724505)
1. The emergency of molecular and transgenic lymphology: what do we (really) know so far?
Suri C
Lymphology; 2006 Mar; 39(1):1-7. PubMed ID: 16724505
[TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
3. New insights into the biology and pathology of the cutaneous lymphatic system.
Hirakawa S; Detmar M
J Dermatol Sci; 2004 Jun; 35(1):1-8. PubMed ID: 15194141
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
Cao Y; Zhong W
Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
[TBL] [Abstract][Full Text] [Related]
5. Development of the lymphatic vascular system: a mystery unravels.
Hong YK; Shin JW; Detmar M
Dev Dyn; 2004 Nov; 231(3):462-73. PubMed ID: 15376314
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling.
Karpanen T; Mäkinen T
Exp Cell Res; 2006 Mar; 312(5):575-83. PubMed ID: 16343484
[TBL] [Abstract][Full Text] [Related]
7. Sox18 induces development of the lymphatic vasculature in mice.
François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology and pathology of lymphangiogenesis.
Karpanen T; Alitalo K
Annu Rev Pathol; 2008; 3():367-97. PubMed ID: 18039141
[TBL] [Abstract][Full Text] [Related]
9. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
[TBL] [Abstract][Full Text] [Related]
10. Endometrial lymphangiogensis.
Rogers PA; Donoghue JF; Girling JE
Placenta; 2008 Mar; 29 Suppl A():S48-54. PubMed ID: 17981324
[TBL] [Abstract][Full Text] [Related]
11. Hereditary vascular anomalies: new insights into their pathogenesis.
Tille JC; Pepper MS
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1578-90. PubMed ID: 15231518
[TBL] [Abstract][Full Text] [Related]
12. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse.
Hägerling R; Pollmann C; Kremer L; Andresen V; Kiefer F
Biochem Soc Trans; 2011 Dec; 39(6):1674-81. PubMed ID: 22103506
[TBL] [Abstract][Full Text] [Related]
13. Role of lymphangiogenesis in cancer.
Sundar SS; Ganesan TS
J Clin Oncol; 2007 Sep; 25(27):4298-307. PubMed ID: 17878481
[TBL] [Abstract][Full Text] [Related]
14. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
15. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE; Detmar M
J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
[TBL] [Abstract][Full Text] [Related]
16. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice.
Hosking B; François M; Wilhelm D; Orsenigo F; Caprini A; Svingen T; Tutt D; Davidson T; Browne C; Dejana E; Koopman P
Development; 2009 Jul; 136(14):2385-91. PubMed ID: 19515696
[TBL] [Abstract][Full Text] [Related]
17. [The role of immune system in colon metastasis. Lymphangiogenesis or lymphedema in cancer tissue].
Stańczyk M; Olszewski WL; Gewartowska M; Maruszyński M
Pol Merkur Lekarski; 2007 May; 22(131):457-9. PubMed ID: 17679395
[TBL] [Abstract][Full Text] [Related]
18. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
19. Pathways targeting tumor lymphangiogenesis.
Wissmann C; Detmar M
Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
[TBL] [Abstract][Full Text] [Related]
20. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
